6 results
diabetes inhibitors dpp4 agonists comparison dosing management mellitus metformin receptor renal sglt2 table
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology ... Summary Mechanisms ... not definitively cause ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
DPP-4 inhibitor, GLP ... Diabetes #Mellitus #DM2 ... #Inpatient #Medications ... #pharmacology # ... comparison #table #endocrinology
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... agent • Does not cause ... #Summary #DM2 # ... diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Summary Mechanisms ... not definitively cause ... #Summary #DM2 # ... diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Increase Incretins (GLP-I ... If you see a patient ... Renal #Dosing #Pharmacology ... Management #Diabetes #DM2 ... #Endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
kidney), which causes ... the patient to ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
No results found for "PocketCard ekg causes collateral pharmacology summary dm2 inpatient medications glp1 endocrinology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #PocketCard #ekg #causes #collateral #pharmacology #summary #dm2 #inpatient #medications #glp1 #endocrinology